Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease
- 1 December 2001
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (12) , 9-13
- https://doi.org/10.1016/s0002-9149(01)02146-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)The American Journal of Cardiology, 1992
- A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial InfarctionNew England Journal of Medicine, 1991
- Prevalence of risk factors in men with premature coronary artery diseaseThe American Journal of Cardiology, 1991
- High-density lipoprotein cholesterol and prognosis after myocardial infarction.Circulation, 1982
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975
- Ischemic Heart Disease, Atherosclerosis, and LongevityCirculation, 1966